The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame
Poliovirus infection causes paralysis in up to 1 in 200 infected persons. The use of safe and effective inactivated poliovirus vaccines and live attenuated oral poliovirus vaccines (OPVs) means that only two pockets of wildtype poliovirus type 1 remain, in Afghanistan and Pakistan. However, OPVs can...
Saved in:
Main Authors: | Sue Ann Costa Clemens (Author), Gustavo Mendes Lima Santos (Author), Isabela Gonzalez (Author), Ralf Clemens (Author) |
---|---|
Format: | Book |
Published: |
Pan American Health Organization,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Poliovirus vaccination during the endgame: insights from integrated modeling
by: Radboud J. Duintjer Tebbens, et al.
Published: (2017) -
Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
by: Radboud J. Duintjer Tebbens, et al.
Published: (2018) -
Massive outbreak of poliomyelitis caused by type-3 wild poliovirus in Angola in 1999
by: F. Valente, et al. -
Re-emergence of poliomyelitis in the Ukraine, caused by circulating vaccine-derived poliovirus type 2 (cVDPV2)
by: Damian Alexander Honeyman, et al.
Published: (2022) -
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?
by: Christian Albert Devaux, et al.
Published: (2024)